Overview

Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer

Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This study will compare the overall survival of participants with locally-advanced, Stage III Non-Small Cell Lung Cancer (NSCLC) with nonsquamous cell histology.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Carboplatin
Cisplatin
Etoposide
Etoposide phosphate
Paclitaxel
Pemetrexed
Vinorelbine